HEPLISAV and/or Placebo

BIOLOGICAL2 trials

Sponsors

Dynavax Technologies Corporation

Conditions

HealthyHepatitis B

Phase 3

Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine

CompletedNCT00435812

Dynavax Technologies CorporationHepatitis B

Start: 2006-12-31End: 2008-03-31Updated: 2019-03-20

Safety and Immunogenicity Study of the Hepatitis B Virus (HBV) Vaccine, HEPLISAV Compared to Engerix-B Vaccine

CompletedNCT01005407

Dynavax Technologies CorporationHealthy

Start: 2010-02-28End: 2011-05-31Updated: 2019-03-20